Sustainability Bayer Increases Its Donations of Medications for Ebola Patients to a Total Value of More than EUR 3.7 Million

Bayer is expanding its aid donations for ebola patients in Liberia and Sierra Leone. The company is supplementing its previous donation of medications with a further delivery of the antibiotic ciprofloxacin to a value of EUR 1.15 million.